Stellest vs Atropine
Understanding Myopia Progression and Why Control Matters
Myopia often appears between ages six and ten and can progress rapidly through the school years. Without intervention, some children lose half a diopter or more each year, doubling their prescription in just a few years.
Eyes grow too fast during this time, stretching the back of the eye and making distance vision increasingly blurry. Slowing that growth early protects long-term eye health and reduces the risk of serious complications later in life.
Certain children are at higher risk for rapid myopia worsening. We look at family history, age at onset, and how much time your child spends on close work versus outdoor play.
- Both parents nearsighted
- Myopia diagnosed before age eight
- High near-work load (long continuous reading or screen sessions, close working distance, limited breaks)
- Limited outdoor time (often aiming for about two hours per day when feasible)
When myopia reaches high levels (commonly minus 6.00 diopters or greater, or longer axial length), the stretched retina becomes fragile and prone to tears, detachments, and degeneration. These complications can threaten vision even with glasses or surgery.
High myopia also increases the lifetime risk of glaucoma and early cataracts. By controlling progression now, we reduce the chance that your child will face these challenges in adulthood.
Watch for frequent complaints that the board at school looks fuzzy again, squinting to see street signs, or sitting closer to the television. If your child needs a stronger prescription every six months, that often suggests fast progression.
Other possible signs include headaches during homework, eye rubbing, and difficulty seeing faces across the room. Let us know right away if you notice any of these changes between routine visits.
What Is Stellest?
Stellest lenses use thousands of tiny optical elements (lenslets) arranged in the peripheral zones of the lens. These change the peripheral focus profile (often described as creating myopic defocus), which is associated with slower axial elongation in many children, while the central zone provides clear distance and near vision.
Studies over one to two years have reported meaningfully slower axial elongation versus single-vision glasses (often around forty to sixty percent on average), but results vary by child and wear time. The treatment is non-invasive and built into everyday eyewear.
We typically fit Stellest for school-age children (often about six through sixteen) who have progressing myopia. Suitability depends on prescription, astigmatism, pupil position, and binocular vision, and the lenses work best when myopia is mild to moderate.
Your child should be able to wear glasses comfortably all day and follow simple care instructions. We will measure the prescription, eye growth rate, and overall eye health before recommending Stellest. If your child falls outside typical criteria, we can discuss alternative myopia control options.
During the fitting appointment, we take precise measurements of your child's face, pupil position, and prescription. The lenses are custom-made and usually arrive within one to two weeks.
- Initial dispense visit to ensure proper fit and comfort
- One-week follow-up to check adaptation
- Instructions on cleaning and handling
- Tips to encourage full-time wear
To achieve the best myopia control results, your child should wear Stellest glasses during full-time waking wear (all school and weekend waking hours), including homework and outdoor activities. Inconsistent wear may reduce benefit.
Clean the lenses daily with a microfiber cloth and lens spray, and store them in a hard case when not in use. Avoid household cleaners or paper towels, which can scratch the special lens surface.
What Is Atropine Treatment?
Low-dose atropine eye drops have minimal effect on focusing at low doses; the mechanism is not fully understood and may involve retinal signaling and scleral remodeling pathways. Recent studies and clinical experience support the use of very low concentrations to slow myopia with minimal side effects.
We prescribe concentrations between zero point zero one and zero point zero five percent, much weaker than the atropine used for eye exams or other conditions. One drop in each eye at bedtime is the typical regimen. In many regions, low-dose atropine is compounded by specialty pharmacies and used off-label for myopia control.
Atropine is safe for most children starting around age five, though we evaluate each case individually. Your child should have progressing myopia and no history of allergic reactions to atropine or related medications.
We review overall health, current medications, and any light sensitivity before starting therapy. Children with certain rare eye conditions or severe allergies may not be good candidates.
We usually begin with the lowest effective concentration and monitor response over three to six months. If progression continues, we may increase the strength slightly or discuss combining atropine with another treatment.
- Baseline eye exam and axial length measurement
- First prescription for a three-month supply
- Follow-up visit to assess tolerance and early response
- Dose adjustment if needed based on side effects or progression rate
Instill one drop in each eye every night before bed, ideally at the same time. Bedtime dosing helps limit daytime light sensitivity and near blur.
Follow the pharmacy label for storage and discard date, as compounded formulations vary (some require refrigeration). Check the expiration date monthly. Wash your hands before handling the dropper, and avoid letting the tip touch the eye or any surface to prevent contamination.
- If a dose is missed, give it as soon as you remember that evening, or skip and resume the next night
- Optionally press gently on the inner corner of the eye for one minute after instilling to reduce systemic absorption
- Never share drops between children
- Keep out of reach of children; if accidental ingestion occurs, contact poison control immediately
- Watch for signs of allergic reaction or severe side effects and call our office if these occur
Comparing Stellest and Atropine
Stellest and low-dose atropine can both slow progression, but the average effect varies. Atropine tends to be more effective at higher low-dose concentrations (for example zero point zero two five to zero point zero five percent) than at zero point zero one percent, and individual response differs.
We evaluate both refractive change and axial length, since treatments can affect these differently. Some children respond better to one therapy than the other. We track axial length and prescription changes every six months to confirm the chosen treatment is working as expected.
Stellest lenses rarely cause significant side effects. A few children notice mild peripheral distortion in the first week, but adaptation is usually quick and complete.
Low-dose atropine can cause side effects that are generally mild at the concentrations we use, and many children experience none at all. Possible effects include:
- Slight pupil dilation leading to mild light sensitivity or glare
- Difficulty reading small print up close or near blur
- Allergic conjunctivitis or eyelid dermatitis
- Headaches related to light sensitivity
- Rarely, systemic anticholinergic symptoms such as dry mouth, flushing, rapid heart rate, or behavioral changes (contact our office urgently if severe)
Mitigation strategies include photochromic lenses or sunglasses for outdoor comfort, wearing a hat in bright sun, reading support with better lighting or larger print, and in some cases a low reading add if near blur persists.
Stellest requires your child to wear glasses all waking hours, which can be challenging for active kids or those who prefer contact lenses. Compliance depends on comfort, peer acceptance, and family encouragement.
Atropine demands a nightly drop routine, which some families find easier to build into bedtime. Forgetting a dose now and then is less disruptive than forgetting glasses at school, but skipping too many nights reduces effectiveness.
Stellest lenses typically cost more than standard glasses, and not all vision plans cover myopia control spectacles. Expect to pay several hundred dollars per pair, plus replacement if the prescription changes or frames break.
Atropine eye drops are often compounded by specialty pharmacies, and insurance coverage varies widely. A three-month supply may range from twenty to one hundred dollars depending on your plan and the concentration prescribed.
In some cases we may recommend using Stellest and low-dose atropine together, especially if one treatment alone does not slow progression enough. Combination therapy may provide additional slowing for some children, but results are variable and evidence is still evolving.
We use combination therapy selectively and monitor for additive side effects and adherence challenges. We monitor closely for any increased light sensitivity or blur and adjust doses as needed.
Monitoring and Follow-Up Care
We schedule comprehensive exams every six months while your child is on myopia control treatment. These visits let us measure prescription changes, eye growth, and overall eye health to confirm the therapy is working.
For many progressing children, annual exams may miss meaningful change; we commonly review every six months while progression is active. Consistent six-month intervals give us the data we need to adjust treatment or reassure you that control is successful.
At each follow-up we measure visual acuity, refraction, and axial length using a non-contact optical instrument. Axial length is the most accurate indicator of eye growth and tells us whether myopia control is effective.
- Updated refraction to determine prescription change
- Axial length measurement to assess eye elongation
- Pupil size and reaction if using atropine
- Retinal health check to rule out complications
If your child struggles with glasses wear or experiences bothersome side effects from atropine, we can switch to the alternative therapy. Most children tolerate the transition well.
In some situations we may adjust timing or overlap strategies; the plan depends on progression rate and side effects. Each plan is tailored to your child's needs and response history.
When stopping atropine, some children experience rebound progression, meaning myopia may worsen more quickly for a period after discontinuation. Tapering the dose and close follow-up may be recommended to manage this risk.
Contact our office right away if your child develops sudden vision loss, flashes of light, a curtain across the vision, or severe eye pain. These symptoms can signal retinal problems that need urgent evaluation.
Also call if you notice persistent redness, discharge, or discomfort after starting atropine, signs of severe allergic reaction such as swelling or difficulty breathing, or if your child complains of constant headaches or dizziness with new Stellest lenses. If accidental ingestion of atropine occurs, contact poison control immediately. We can often resolve minor issues with simple adjustments.
Lifestyle and Environmental Measures
Spending time outdoors in natural daylight is associated with slower myopia progression. We recommend aiming for about two hours of outdoor time each day when feasible, in addition to optical or medication treatment.
Outdoor time does not need to be continuous or involve sports. Simple activities like walking, playing at the park, or eating lunch outside all contribute. Bright outdoor light appears to be the key protective factor.
While near work such as reading and screen time is important for learning, long continuous sessions at close range may contribute to progression. We recommend regular breaks using the twenty-twenty-twenty rule: every twenty minutes, look at something twenty feet away for twenty seconds.
Encourage your child to hold books and devices at a comfortable working distance (about elbow to knuckle length), use good lighting to reduce strain, and take frequent breaks during homework sessions. These habits complement Stellest or atropine therapy.
Frequently Asked Questions
The ideal window is as soon as progressive myopia is diagnosed, often between ages six and ten. Starting early maximizes the total slowing effect over the years of active eye growth, giving your child the best chance of ending up with lower final myopia.
We will evaluate your child's individual progression pattern, risk factors, and readiness for treatment to determine the best time to begin.
Most children continue treatment until their mid to late teens, when natural eye growth slows and progression stabilizes. We review the data each year and may taper or stop therapy once we see two consecutive exams with no significant change.
The exact duration depends on when your child started treatment, how fast their eyes were growing, and when their individual growth pattern plateaus.
Resistance is common at first. We work with families to address comfort issues, peer concerns, and daily routines. Sometimes switching modalities or involving your child in choosing frame styles improves cooperation, and open communication with positive reinforcement goes a long way.
If challenges persist, we can explore contact lens options or adjust the treatment plan. The key is finding an approach your child will follow consistently.
Myopia control slows progression but does not eliminate the existing nearsightedness. Your child will still need glasses or contact lenses for clear distance vision. The goal is to keep the prescription from climbing into the high range that carries greater health risks.
Think of myopia control as protecting future eye health rather than curing current nearsightedness.
Yes, specialty multifocal soft lenses and overnight orthokeratology lenses are proven myopia control options. If your child is responsible enough for lens hygiene and prefers contacts over glasses, we can discuss whether one of these alternatives fits your situation.
Contact lens myopia control requires maturity and diligent cleaning routines, but many children handle these responsibilities well starting around age eight to ten.
Treatment is most effective during the active growth years, but older children and even teenagers can still benefit if their myopia is progressing. We assess growth rate and remaining years of progression risk to decide if starting therapy makes sense at any age.
Even modest slowing in the later teen years can make a meaningful difference in final prescription and long-term eye health.
Getting Help for Stellest vs Atropine
Choosing between Stellest and atropine depends on your child's age, lifestyle, tolerance for drops or glasses, and how fast their myopia is advancing. Outdoor time and healthy near-work habits are recommended alongside any optical or medication approach. Our eye doctor will review all the factors with you, track progress over time, and adjust the plan to protect your child's vision for the long term.